Discover your next big idea at PACK EXPO Las Vegas this September
Experience a breakthrough in packaging & processing and transform your business with solutions from 2,300 suppliers spanning all industries.
REGISTER NOW & SAVE

Pharmaceutical packaging makes news

While more details emerge in the Novartis recall, a ’60 Minutes’ segment, and a ban on inhalers shine the media spotlight on pharmaceutical and biologics packaging.

Novartis Bufferin
Novartis Bufferin

New developments were reported in the voluntary Novartis recall in “What you need to know about the Novartis drug recall,” from The Daily Nightly on MSNBC.com. It noted, “The FDA warned Monday [Jan. 9] some of Novartis’ over-the-counter pills may have been packaged with prescription opioid drugs sold by Endo Pharmaceuticals, which are packaged at the same facility. Those drugs include Percocet, Endocet, Opana and Zydone.”
 

On Jan. 8, Novartis Consumer Health Inc. announced a voluntarily nationwide recall of certain OTC products due to the potential presence of foreign tablets or chipped or broken tablets or gelcaps. These included packages of Excedrin, Bufferin, Gas-X, and NoDoz products. The announcement garnered considerable media attention, showing photos of packaged products and footage of pharmaceutical packaging lines.
 

Packaging also made the news in “Stem Cell Fraud,” a Jan. 8 “60 Minutes” segment with correspondent Scott Pelley. As the episode’s script of the segment reads, “We had the cells sent by the highest medical standard. Duke University suggested we use something called a dry shipper, cooled with liquid nitrogen. We sent the dry shipper to Stem Tech. Stem Tech sent the frozen cells to us, and we forwarded them to Joanne Kurtzberg. A computer chip inside our package verified the cells were properly frozen all the way.”
 

To clarify, 60 Minutes said that Dan Ecklund, founder and director of Stem Tech Labs of Equador, is a person it has been tracking regarding stem cell-related claims. Dr. Kurtzberg, said the show’s script, is a scientist conducting advanced studies in stem cells.

Looking back to Dec. 30, 2011, packaging was again in the spotlight, this time on the report, “Over-the-counter inhalers taken off the market,” which aired on NBC in Fort Myers, FL. The story/video noted, “Local pharmacies are preparing to take the only over-the-counter asthma inhaler off the shelves. It’s because of concerns its propellant is damaging the ozone layer.” The report said that the chlorofluorocarbon (CFC) propellant “is now banned in the U.S. by the Food and Drug Administration because it’s responsible for 1/10th of a percent of global CFC emissions.”
 

Break out of the ordinary: see what’s new in packaging & processing!
At PACK EXPO Las Vegas, you’ll see machinery in action and new tech from 2,300 suppliers, collaborate with experts and explore transformative solutions. Join us this September to experience a breakthrough in packaging and processing.
REGISTER NOW AND SAVE
Break out of the ordinary: see what’s new in packaging & processing!
Coding, Marking, and Labeling Innovations Report
Explore our editor-curated report featuring cutting-edge coding, labeling, and RFID innovations from PACK EXPO 2024. Discover high-speed digital printing, sustainable label materials, automated labeling systems, and advanced traceability solutions that are transforming packaging operations across industries.
Access Report
Coding, Marking, and Labeling Innovations Report